Emc Capital Management Silk Road Medical Inc Transaction History

Emc Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$29.24 - $44.06 $756,555 - $1.14 Million	-25,874 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$39.32 - $61.61 $262,028 - $410,569	6,664 Added 34.69%	25,874 $1.1 Million
Q2 2021 Aug 09, 2021	SELL	$44.66 - $63.06 $145,145 - $204,945	-3,250 Reduced 14.47%	19,210 $919,000
Q1 2021 May 05, 2021	SELL	$46.31 - $62.7 $99,010 - $134,052	-2,138 Reduced 8.69%	22,460 $1.14 Million
Q4 2020 Feb 24, 2021	BUY	$55.51 - $69.94 $1.37 Million - $1.72 Million	24,598 New	24,598 $1.55 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.